Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Outcomes for ST-elevation myocardial infarction (STEMI) have improved, but non-ST-segment-elevation acute coronary syndromes (NSTEACS) still exhibit high mortality.
• Longer-term mortality (4 years) for NSTEACS is approximately double that of STEMI.
• NSTEACS patients are generally older, potentially contributing to poorer prognosis, though the exact reasons remain unclear.

Purpose of the Study:

• To review and discuss optimal treatment strategies for NSTEACS.
• To clarify the role of coronary angiography in NSTEACS management.
• To provide guidance on patient selection and optimal timing for coronary angiography.

Main Methods:

• Literature review of current evidence and treatment guidelines for NSTEACS.
• Analysis of factors influencing prognosis in NSTEACS patients.
• Discussion of diagnostic and therapeutic interventions, focusing on coronary angiography.

Main Results:

• Optimal therapy for NSTEACS is less defined compared to STEMI.
• Coronary angiography plays a crucial role, but optimal timing and patient selection require careful consideration.
• Evidence-based strategies for managing NSTEACS are presented.

Conclusions:

• NSTEACS remains associated with significant long-term mortality.
• A clear, evidence-based approach to coronary angiography and overall treatment is essential for improving NSTEACS outcomes.
• Further research may elucidate specific factors contributing to NSTEACS prognosis.